These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Flavonoids and related compounds as inhibition of arachidonic acid peroxidation. Baumann J, von Bruchhausen F, Wurm G. Prostaglandins; 1980 Oct; 20(4):627-39. PubMed ID: 6781013 [Abstract] [Full Text] [Related]
3. A novel preparation of human platelet lipoxygenase. Characteristics and inhibition by a variety of phenyl hydrazones and comparisons with other lipoxygenases. Wallach DP, Brown VR. Biochim Biophys Acta; 1981 Feb 23; 663(2):361-72. PubMed ID: 6783111 [Abstract] [Full Text] [Related]
4. Decreasing inhibitory potency of prostaglandin synthetase inhibitors during their cooxidative metabolism. Studies on aminophenols, pyrazolon derivatives and 1,3-diphenylisobenzofuran. Baumann J, von Bruchhausen F, Wurm G. Pharmacology; 1983 Feb 23; 27(5):267-80. PubMed ID: 6419240 [Abstract] [Full Text] [Related]
5. Role of arachidonate lipoxygenase and cyclooxygenase products in insulin and glucagon secretion from rat pancreatic islets. Morgan RO, Pek SB. Metabolism; 1984 Oct 23; 33(10):928-35. PubMed ID: 6434899 [Abstract] [Full Text] [Related]
6. Interactions of inhibitors of the lipoxygenase and cyclooxygenase pathways with a supplementary binding site on soybean lipoxygenase. Baumann I, Baumann J, Wurm G. Br J Pharmacol; 1984 Dec 23; 83(4):959-64. PubMed ID: 6440614 [Abstract] [Full Text] [Related]
7. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. Moroney MA, Alcaraz MJ, Forder RA, Carey F, Hoult JR. J Pharm Pharmacol; 1988 Nov 23; 40(11):787-92. PubMed ID: 2907559 [Abstract] [Full Text] [Related]
8. Lipoxygenase pathway in islet endocrine cells. Oxidative metabolism of arachidonic acid promotes insulin release. Metz S, VanRollins M, Strife R, Fujimoto W, Robertson RP. J Clin Invest; 1983 May 23; 71(5):1191-205. PubMed ID: 6406544 [Abstract] [Full Text] [Related]
9. The effect of some flavonoids on non-enzymatic lipid oxidation and enzymatic oxidation of arachidonic acid. Robak J, Duniec Z, Rzadkowska-Bodalska H, Olechnowicz-Stepień W, Cisowski W. Pol J Pharmacol Pharm; 1986 May 23; 38(5-6):483-91. PubMed ID: 3106941 [Abstract] [Full Text] [Related]
11. Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase. Hidaka T, Hosoe K, Ariki Y, Takeo K, Yamashita T, Katsumi I, Kondo H, Yamashita K, Watanabe K. Jpn J Pharmacol; 1984 Sep 23; 36(1):77-85. PubMed ID: 6438380 [Abstract] [Full Text] [Related]
12. Effects of lipoxygenase and cyclooxygenase inhibitors on glucose-stimulated insulin secretion from the isolated perfused rat pancreas. Walsh MF, Pek SB. Life Sci; 1984 Apr 30; 34(18):1699-706. PubMed ID: 6427544 [Abstract] [Full Text] [Related]
14. Interactions of a variety of lipoxygenase inhibitors with a supplementary binding site on soybean lipoxygenase. Baumann J, Wurm G, Baumann I. Agents Actions; 1985 Mar 30; 16(1-2):63-5. PubMed ID: 3923789 [Abstract] [Full Text] [Related]
15. (+)-Cyanidanol-3 as inhibitor of prostaglandin synthetase. Studies on renal medulla and liver of the rat in vitro and in vivo. Baumann J, von Bruchhausen F. Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan 30; 306(1):85-7. PubMed ID: 106308 [Abstract] [Full Text] [Related]